Xu J - Search Results

1

The Value of DNA Quantitative Cytology Test for the Screening of Endometrial Cancer.

Yang BH, Yu MX, Xu J, Su Y, Ai ZH. Yang BH, et al. Among authors: xu j. Cancer Manag Res. 2019 Dec 11;11:10383-10391. doi: 10.2147/CMAR.S225672. eCollection 2019. Cancer Manag Res. 2019. PMID: 31849527 Free PMC article.

2

Quantitative DNA methylation analysis of paired box gene 1 and LIM homeobox transcription factor 1 α genes in cervical cancer.

Xu L, Xu J, Hu Z, Yang B, Wang L, Lin X, Xia Z, Zhang Z, Zhu Y. Xu L, et al. Among authors: xu j. Oncol Lett. 2018 Apr;15(4):4477-4484. doi: 10.3892/ol.2018.7872. Epub 2018 Jan 26. Oncol Lett. 2018. PMID: 29541217 Free PMC article.

3

Genetic variation of the CYP17 and susceptibility to endometrial cancer: a meta-analysis.

Xu J, Lin X, Zhu H, Zhang Z, Yang B. Xu J, et al. Mol Biol Rep. 2013 Aug;40(8):5085-91. doi: 10.1007/s11033-013-2609-0. Epub 2013 May 7. Mol Biol Rep. 2013. PMID: 23649771

4

Assessing methylation status of PAX1 in cervical scrapings, as a novel diagnostic and predictive biomarker, was closely related to screen cervical cancer.

Xu J, Xu L, Yang B, Wang L, Lin X, Tu H. Xu J, et al. Among authors: xu l. Int J Clin Exp Pathol. 2015 Feb 1;8(2):1674-81. eCollection 2015. Int J Clin Exp Pathol. 2015. PMID: 25973053 Free PMC article.

5

LINC00958 facilitates cervical cancer cell proliferation and metastasis by sponging miR-625-5p to upregulate LRRC8E expression.

Wang L, Zhong Y, Yang B, Zhu Y, Zhu X, Xia Z, Xu J, Xu L. Wang L, et al. Among authors: xu l, xu j. J Cell Biochem. 2020 Mar;121(3):2500-2509. doi: 10.1002/jcb.29472. Epub 2019 Nov 5. J Cell Biochem. 2020. PMID: 31691355

6

MicroRNA-196b promotes cell growth and metastasis of ovarian cancer by targeting ZMYND11.

Zhang Z, Xu L, Hu Z, Yang B, Xu J. Zhang Z, et al. Among authors: xu l, xu j. Minerva Med. 2022 Aug;113(4):707-717. doi: 10.23736/S0026-4806.20.06654-9. Epub 2020 Jun 5. Minerva Med. 2022. PMID: 32512976

7

LncRNA BBOX1-AS1 upregulates HOXC6 expression through miR-361-3p and HuR to drive cervical cancer progression.

Xu J, Yang B, Wang L, Zhu Y, Zhu X, Xia Z, Zhao Z, Xu L. Xu J, et al. Among authors: xu l. Cell Prolif. 2020 Jul;53(7):e12823. doi: 10.1111/cpr.12823. Epub 2020 Jun 9. Cell Prolif. 2020. PMID: 32515533 Free PMC article.

8

The sphingosine kinase 2 inhibitor ABC294640 inhibits cervical carcinoma cell growth.

Xu L, Jin L, Yang B, Wang L, Xia Z, Zhang Q, Xu J. Xu L, et al. Among authors: xu j. Oncotarget. 2017 Dec 19;9(2):2384-2394. doi: 10.18632/oncotarget.23415. eCollection 2018 Jan 5. Oncotarget. 2017. PMID: 29416779 Free PMC article.

9

Effects of Information Technology-Based Two-Way Referral on Diagnosis and Management of Cervical Lesions: A Cluster-Controlled Trial in China.

Jin LM, Xu L, Xu J, Zhang XH, Zhang LL, Zhu LH, Yang HB, Zhang L, Yao Y, Feng H. Jin LM, et al. Among authors: xu l, xu j. Asia Pac J Public Health. 2018 Jul;30(5):491-499. doi: 10.1177/1010539518786635. Epub 2018 Jul 11. Asia Pac J Public Health. 2018. PMID: 29992824 Clinical Trial.

10

The Prevalence of Thrice, Twice, and Once Human Papillomavirus DNA Positivity in Older Chinese Women.

Hu G, Xu J, Xu L, Jin L. Hu G, et al. Among authors: xu l, xu j. Front Med (Lausanne). 2020 Sep 2;7:391. doi: 10.3389/fmed.2020.00391. eCollection 2020. Front Med (Lausanne). 2020. PMID: 32984359 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

67,649 results

Search Page

Filters